The FDA recalled cough lozenges due to quality issues
13 april 2026 в 22:37
In April 2026, the U.S. Food and Drug Administration (FDA) recalled a specific brand of cough drops, classifying it as a Class II recall. As spring can be a time for allergies, coughs, and colds for some people, many are curious about which cough drops were taken off the shelves.
Here is information about which cough drops were voluntarily recalled by the manufacturer and what to do if you have already purchased them.
The following packages of menthol cough drops have been recalled:
The menthol cough drops were recalled as a result of an inspection of the manufacturing facility conducted on August 15, 2025. The FDA recommended the recall because observations «may affect product quality» however, specific details were not provided.
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. from China initiated the recall on March 20, 2026. The FDA then classified it as a Class II recall, which means that contact with the «violative product» may lead to «temporary or medically reversible adverse health consequences», - according to the agency’s information
Here is information about which cough drops were voluntarily recalled by the manufacturer and what to do if you have already purchased them.
The following packages of menthol cough drops have been recalled:
The menthol cough drops were recalled as a result of an inspection of the manufacturing facility conducted on August 15, 2025. The FDA recommended the recall because observations «may affect product quality» however, specific details were not provided.
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. from China initiated the recall on March 20, 2026. The FDA then classified it as a Class II recall, which means that contact with the «violative product» may lead to «temporary or medically reversible adverse health consequences», - according to the agency’s information
© Smirnova Olga
